G-PERT

DRUG2 trials

Sponsors

AHS Cancer Control Alberta, University of Alberta

Conditions

Head and Neck NeoplasmsThyroid Gland DiseasesThyroid Neoplasms

Phase 2

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

WithdrawnNCT01747512

AHS Cancer Control AlbertaHead and Neck Neoplasms, Thyroid Neoplasms

Updated: 2017-11-14

Phase 3

A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery

CompletedNCT02980679

University of AlbertaThyroid Gland Diseases

Start: 2017-03-03End: 2019-02-25Updated: 2022-04-11